Fewer TOLS patients had preoperative jaundice, lower levels of TB, ALT, and INR, higher levels of albumin, earlier T, N, and AJCC tumor stages, a larger extent of hepatectomy, and fewer patients with neoadjuvant therapy. This evidence concerns the gene GPT and neoplasm.